1st Quarter - Report
THE MCMANUS GROUP for ALLERGAN INC
Firm
Client
Income
$40,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to follow-on biologics. Support for H.R. 1548, "Pathway for Biosimilars Act." Opposition to H.R. 1427, "Promoting Innovation and Access to Life-Saving Medicine Act."
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| NICK SHIPLEY New | Legislative Director, Rep. Jay Inslee |
Medicare/Medicaid MMM
Implementation of the Medicaid drug rebate program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.